Taking informed consent procedure
METASTASES
Before performing any study-related procedures, written informed consent (IC) will be obtained from the patient by the study physician. Before the screening visit, all patients will have been worked up according to standard institutional protocols for patients with GC. These include esophagogastroduodenoscopy with biopsy; chest and abdominal computed tomography (CT); diagnostic laparoscopy with peritoneal lavage and biopsy for patients with ≥ cT2 GC without extra-abdominal metastases on CT scan. At the screening visit physician will provide the patient with information and details about a study and will answer all the questions that the patient has. After the patient indicates that he/she had enough time to consider participation and clearly expresses willingness to be included in the study physician and patient will sign the IC. A copy of the signed IC will be given to the patient.